Allergen-induced Eosinophil Cytolysis Is a Primary Mechanism for Granule Protein Release in Human Upper Airways
- 1 July 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (1) , 304-312
- https://doi.org/10.1164/ajrccm.160.1.9809048
Abstract
Cytotoxic eosinophil granule proteins are considered important in the pathogenesis of allergic airway diseases such as rhinitis and asthma. To explore the cellular mechanisms behind eosinophil granule release in human allergic airways, 16 symptom-free patients with seasonal allergic rhinitis were challenged daily with allergen during 1 wk. Nasal lavage samples and biopsies, obtained before and 24 h after the last allergen exposure, were processed for immunohistochemical and electron microscopic analysis. The allergen challenges produced nasal symptoms, marked tissue eosinophilia, and an increase in lavage fluid levels of eosinophil cationic protein (ECP). The nasal mucosa areas with intense extracellular immunoreactivity for ECP were associated with abundant free eosinophil granules. Electron microscopy confirmed the free granules and revealed that all mucosal eosinophils were involved in granule release, either by cytolysis (33%) or piecemeal degranulation (PMD) (67%). Resting or apoptotic eosinophils were not observed. Cytolytic eosinophils had less signs of intracellular granule release (p < 0. 001) and a higher content of intact granules (p < 0.001) compared with viable eosinophils in the same tissue. This study demonstrates eosinophil cytolysis (ECL) as a distinct mechanism for granule mediator release in human allergic airway mucosa. The nature and extent of the ECL and its product (i.e., protein-laden extracellular granules) indicate that allergen-induced cytolysis is a primary and major mechanism for the release of eosinophil proteins in human allergic airway inflammation in vivo.Keywords
This publication has 37 references indexed in Scilit:
- Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophilsJournal of Allergy and Clinical Immunology, 1998
- The Shape of Cell DeathBiochemical and Biophysical Research Communications, 1997
- In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.Journal of Clinical Investigation, 1996
- Allergen challenge-induced entry of α-macroglobulin and tryptase into human nasal and bronchial airwaysJournal of Allergy and Clinical Immunology, 1995
- Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.Journal of Clinical Investigation, 1995
- Quantitation of eosinophil Major Basic Protein cytotoxicity to rodent respiratory epitheliumInflammation Research, 1992
- Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: Extensivein vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cellsThe Journal of Pathology, 1991
- Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic DermatitisNew England Journal of Medicine, 1985
- Episodic Angioedema Associated with EosinophiliaNew England Journal of Medicine, 1984
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982